رجوع
نطاق اليوم
KWD 29.02
KWD 29.98
نطاق 52 أسبوعًا
KWD 28.29
KWD 43.18
حجم التداول
347,113
متوسط 50 يوم / 200 يوم
KWD 34.28
/
KWD 35.10
الإغلاق السابق
KWD 29.78
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -128.8 | 0.3 |
| P/B | 3.0 | 2.9 |
| ROE % | -2.4 | 3.7 |
| Net Margin % | -2.1 | 3.8 |
| Rev Growth 5Y % | 18.2 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 50.670
+71.1%
Low: KWD 44.000
High: KWD 55.000
مكرر الربحية المستقبلي
596.8
ربحية السهم المستقبلية
KWD 0.050
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
600 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.050
KWD 1.036 – KWD 1.058
|
990 M | 2 |
| FY2029 |
KWD 0.730
KWD 0.721 – KWD 0.735
|
860 M | 2 |
| FY2028 |
KWD 0.600
KWD 0.410 – KWD 0.780
|
770 M | 4 |
النقاط الرئيسية
Revenue grew 18.15% annually over 5 years — strong growth
Debt/Equity of 0.18 — conservative balance sheet
Generating 48.28M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.27%
Capital efficient — spends only 1.69% of revenue on capex
النمو
Revenue Growth (5Y)
18.15%
Revenue (1Y)14.88%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-2.40%
ROIC-0.45%
Net Margin-2.14%
Op. Margin-0.64%
الأمان
Debt / Equity
0.18
Current Ratio3.96
Interest Coverage-0.59
التقييم
P/E Ratio
-128.83
P/B Ratio3.00
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.88% | Revenue Growth (3Y) | 15.71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18.15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 534.53M | Net Income (TTM) | -11.45M |
| ROE | -2.40% | ROA | -1.75% |
| Gross Margin | 74.41% | Operating Margin | -0.64% |
| Net Margin | -2.14% | Free Cash Flow (TTM) | 48.28M |
| ROIC | -0.45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.18 | Current Ratio | 3.96 |
| Interest Coverage | -0.59 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -128.83 | P/B Ratio | 3.00 |
| P/S Ratio | 2.76 | PEG Ratio | 2.21 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.47B | Enterprise Value | 1.40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 534.53M | 465.31M | 399.25M | 330.38M | 274.33M |
| Net Income | -11.45M | -44.70M | -30.44M | -46.47M | 50.20M |
| EPS (Diluted) | -0.24 | -0.95 | -0.66 | -1.02 | 1.09 |
| Gross Profit | 397.74M | 347.52M | 300.37M | 245.94M | 205.86M |
| Operating Income | -3.45M | -40.01M | -26.68M | -42.67M | 55.21M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 654.18M | 609.33M | 613.93M | 585.45M | 615.31M |
| Total Liabilities | 162.24M | 148.36M | 147.76M | 128.69M | 131.56M |
| Shareholders' Equity | 491.94M | 460.97M | 466.17M | 456.75M | 483.76M |
| Total Debt | 88.02M | 76.53M | 74.49M | 74.55M | 75.65M |
| Cash & Equivalents | 167.43M | 122.72M | 84.31M | 58.10M | 43.65M |
| Current Assets | 322.52M | 267.83M | 266.25M | 215.21M | 196.08M |
| Current Liabilities | 81.52M | 73.42M | 74.57M | 58.39M | 56.45M |